Site Map

Lipoprotein-a

Lp(a)

Lipoproteins are molecules made of proteins and fat. They carry cholesterol and similar substances through the blood.

A blood test can be done to measure a specific type of lipoprotein called lipoprotein-a, or Lp(a). A high level of Lp(a) is considered a risk factor for heart disease.

I Would Like to Learn About:

How the Test is Performed

A blood sample is needed.

How to Prepare for the Test

You will be asked not to eat anything for 12 hours before the test.

DO NOT smoke before the test.

How the Test will Feel

A needle is inserted to draw blood. You may feel slight pain, or only a prick or stinging sensation. Afterward, there may be some throbbing.

Why the Test is Performed

High levels of lipoproteins can increase the risk for heart disease. The test is done to check your risk for atherosclerosis, stroke, and heart attack.

It is not yet clear if this measurement leads to improved benefits for patients. Therefore, many insurance companies DO NOT pay for it.

The American Heart Association and American College of Cardiology DO NOT recommend the test for most adults who DO NOT have symptoms. It may be useful for people at higher risk because of a strong family history of cardiovascular disease.

Normal Results

Normal values are below 30 mg/dL (milligrams per deciliter), or 1.7 mmol/L.

Note: Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.

The example above shows the common measurements for results of these tests. Some laboratories use different measurements or may test different specimens.

What Abnormal Results Mean

Higher than normal values of Lp(a) are associated with a high risk for atherosclerosis, stroke, and heart attack.

Considerations

Lp(a) measurements may provide more detail about your risk for heart disease, but the added value of this test beyond a standard lipid panel is unknown.

Related Information

Protein in diet
Hardening of the arteries
Stroke
Heart attack

References

Genest J, Libby P. Lipoprotein disorders and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 48.

Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;129(25 Suppl 2):S49-S73. PMID: 24222018 www.ncbi.nlm.nih.gov/pubmed/24222018.

Semenkovich CF. Disorders of lipid metabolism. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 206.

BACK TO TOP

Review Date: 5/16/2018  

Reviewed By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2019 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.